These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28807403)

  • 1. Prevalence of Hyperuricemia in Patients With Acute Heart Failure With Either Reduced or Preserved Ejection Fraction.
    Palazzuoli A; Ruocco G; De Vivo O; Nuti R; McCullough PA
    Am J Cardiol; 2017 Oct; 120(7):1146-1150. PubMed ID: 28807403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Hyperuricemia in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; Beltrami M; Giordano N; Nuti R; McCullough PA
    Am J Cardiol; 2016 May; 117(10):1616-1621. PubMed ID: 27040576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
    Bavishi C; Ather S; Bambhroliya A; Jneid H; Virani SS; Bozkurt B; Deswal A
    Am J Cardiol; 2014 Jun; 113(11):1834-8. PubMed ID: 24837261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction With Versus Without Hyperuricemia or Gout.
    Carnicelli AP; Clare R; Chiswell K; Lytle B; Bjursell M; Perl S; Andersson K; Hedman K; Pagidipati N; Vemulapalli S; Roe MT; Mentz RJ
    Am J Cardiol; 2020 Jul; 127():64-72. PubMed ID: 32386813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
    Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction.
    Al-Jarallah M; Rajan R; Al-Zakwani I; Dashti R; Bulbanat B; Ridha M; Sulaiman K; Alsheikh-Ali AA; Panduranga P; AlHabib KF; Al Suwaidi J; Al-Mahmeed W; AlFaleh H; Elasfar A; Al-Motarreb A; Bazargani N; Asaad N; Amin H
    ESC Heart Fail; 2020 Feb; 7(1):297-305. PubMed ID: 31825180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
    Heart; 2018 Mar; 104(6):525-532. PubMed ID: 28982721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.
    Lund LH; Claggett B; Liu J; Lam CS; Jhund PS; Rosano GM; Swedberg K; Yusuf S; Granger CB; Pfeffer MA; McMurray JJV; Solomon SD
    Eur J Heart Fail; 2018 Aug; 20(8):1230-1239. PubMed ID: 29431256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance).
    Caughey MC; Avery CL; Ni H; Solomon SD; Matsushita K; Wruck LM; Rosamond WD; Loehr LR
    Am J Cardiol; 2014 Dec; 114(12):1850-4. PubMed ID: 25438912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
    Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery disease and 10-year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction.
    Rusinaru D; Houpe D; Szymanski C; Lévy F; Maréchaux S; Tribouilloy C
    Eur J Heart Fail; 2014 Sep; 16(9):967-76. PubMed ID: 25111982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperuricemia predicts adverse outcomes in patients with heart failure.
    Hamaguchi S; Furumoto T; Tsuchihashi-Makaya M; Goto K; Goto D; Yokota T; Kinugawa S; Yokoshiki H; Takeshita A; Tsutsui H;
    Int J Cardiol; 2011 Sep; 151(2):143-7. PubMed ID: 20542341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of hyperuricemia with mortality in heart failure patients with preserved ejection fraction.
    Shimizu T; Yoshihisa A; Kanno Y; Takiguchi M; Sato A; Miura S; Nakamura Y; Yamauchi H; Owada T; Abe S; Sato T; Suzuki S; Oikawa M; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh S; Takeishi Y
    Am J Physiol Heart Circ Physiol; 2015 Oct; 309(7):H1123-9. PubMed ID: 26297226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction.
    Kato N; Kinugawa K; Shiga T; Hatano M; Takeda N; Imai Y; Watanabe M; Yao A; Hirata Y; Kazuma K; Nagai R
    J Cardiol; 2012 Jul; 60(1):23-30. PubMed ID: 22445598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are atherosclerotic risk factors associated with a poor prognosis in patients with hyperuricemic acute heart failure? The evaluation of the causal dependence of acute heart failure and hyperuricemia.
    Okazaki H; Shirakabe A; Kobayashi N; Hata N; Shinada T; Matsushita M; Yamamoto Y; Shibata Y; Shibuya J; Shiomura R; Nishigoori S; Asai K; Shimizu W
    Heart Vessels; 2017 Apr; 32(4):436-445. PubMed ID: 27672076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study.
    Vedin O; Lam CSP; Koh AS; Benson L; Teng THK; Tay WT; Braun OÖ; Savarese G; Dahlström U; Lund LH
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28615366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.